Resource Guide: Scientific review of Ibrance and Interstitial Lung Disease risk

This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.

Featured analysis

Scientific review of Ibrance and Interstitial Lung Disease risk

A focused review of background, context, and source material on this subject.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

Mayo Clinic — Diseases & Conditions

Reference: Mayo Clinic — Diseases & Conditions

Authoritative source for clinical, regulatory, and public-health background reading.